Cardiovascular endpoints | ||||||
---|---|---|---|---|---|---|
Methylxanthine | Dose | Pericardial edema | Decreased blood flow | Absent blood flow | Thrombosis | Hemorrhage |
Aminophylline | LC | 2% | 1% | 1% | 0 | 0 |
HC | 14% | 16% | 6% | 0 | 2% | |
Caffeine | LC | 0.01% | 0.01% | 0 | 0 | 0 |
HC | 12% | 6.5% | 9.8% | 0 | 5.4% | |
Diprophylline | LC | 0.01% | 0.01% | 0.01% | 0 | 0 |
HC | 7.8% | 4.95% | 2.94% | 0 | 0.01% | |
Doxofylline | LC | 4% | 4% | 12% | 0 | 0 |
HC | 13.7% | 8.21% | 11% | 0 | 0 | |
Etofylline | LC | 0.8% | 3% | 2.5% | 0 | 0 |
HC | 10.2% | 5.6% | 7.8% | 0 | 0 | |
IBMX | LC | 3.8% | 0 | 0.03% | 0 | 0 |
HC | 18% | 12.5% | 15.3% | 0 | 0.01% | |
Pentoxifylline | LC | 0 | 0 | 0 | 0 | 0 |
HC | 8.5% | 8.5% | 5.7% | 0 | 0 | |
Theophylline | LC | 0.01% | 0.01% | 0 | 0 | 0 |
HC | 17% | 9.2% | 13.8% | 0 | 7.7% |
Affected endpoints of cardiovascular system at 48 hpf. The table illustrate the percentage of embryos with a particular endpoint affected at the lowest and highest tested concentration
LC lowest concentration, HC highest concentration